Amy Medlock

Dr. Amy Medlock

1. Department of Biochemistry and Molecular Biology, University of Georgia, Athens, GA 30602, USA</br> 2. Augusta University/University of Georgia Medical Partnership, University of Georgia, Athens, GA 30602, USA
orcid

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 February 2006 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
CPCorinne Pondarré
Corinne Pondarré
BABrendan B. Antiochos
Brendan B. Antiochos
DCDean R. Campagna
Dean R. Campagna
SCStephen L. Clarke
Stephen L. Clarke
Eric GreerEric Greer
Eric Greer
MFMark D. Fleming
Mark D. Fleming
Proteins with iron–sulfur (Fe–S) clusters participate in multiple metabolic pathways throughout the cell. The mitochondrial ABC half-transporter Abcb7, which is mutated in X-linked sideroblastic anemia with ataxia in humans, is a functional ortholog of yeast Atm1p and is predicted to export a mitochondrially derived metabolite required for cytosolic Fe–S cluster assembly. Using an inducible Cre/loxP system to delete exons 9 and 10 of the Abcb7 gene, we examined the phenotype of mice deficient in Abcb7. We found that Abcb7 was essential in extra-embryonic tissues early in gestation and that the mutant allele exhibits an X-linked parent-of-origin lethality effect. Furthermore, using X-chromosome inactivation assays and tissue-specific deletions, Abcb7 was found to be essential for the development and function of numerous other cell types and tissues. A notable exception to this was liver, where loss of Abcb7 impaired cytosolic Fe–S cluster assembly but was not lethal. In this situation, control of iron regulatory protein 1, a key cytosolic modulator of iron metabolism, which is responsive to the availability of cytosolic Fe–S clusters, was impaired and contributed to the dysregulation of hepatocyte iron metabolism. Altogether, these studies demonstrate the essential nature of Abcb7 in mammals and further substantiate a central role for mitochondria in the biogenesis of cytosolic Fe–S proteins.

1 December 2000 in Cellular and Molecular Life Sciences
Verified
Journal Article
Closed access
PDF file
HDH. A. Dailey
H. A. Dailey
TDT. A. Dailey
T. A. Dailey
CWC.-K. Wu
C.-K. Wu
Amy MedlockAmy Medlock
Amy Medlock
JRJ. P. Rose
J. P. Rose
KWK.-F. Wang
K.-F. Wang

29 February 2020 in Cells
Verified
Journal Article
Open access
PDF file
SSSamantha Swenson
Samantha Swenson
CMCourtney Moore
Courtney Moore
JMJason R. Marcero
Jason R. Marcero
Amy MedlockAmy Medlock
Amy Medlock
ARAmit R. Reddi
Amit R. Reddi
Oleh KhalimonchukOleh Khalimonchuk
Oleh Khalimonchuk
Heme is a ubiquitous and essential iron containing metallo-organic cofactor required for virtually all aerobic life. Heme synthesis is initiated and completed in mitochondria, followed by certain covalent modifications and/or its delivery to apo-hemoproteins residing throughout the cell. While the biochemical aspects of heme biosynthetic reactions are well understood, the trafficking of newly synthesized heme—a highly reactive and inherently toxic compound—and its subsequent delivery to target proteins remain far from clear. In this review, we summarize current knowledge about heme biosynthesis and trafficking within and outside of the mitochondria.

7 November 2012 in Nature
Verified
Journal Article
Open access
PDF file
DSDhvanit I. Shah
Dhvanit I. Shah
NTNaoko Takahashi-Makise
Naoko Takahashi-Makise
JCJeffrey D. Cooney
Jeffrey D. Cooney
LLLiangtao Li
Liangtao Li
ISIman J. Schultz
Iman J. Schultz
BPBarry H. Paw
Barry H. Paw
Atpif1, a mitochondrial ATPase inhibitor, was identified as a zebrafish anemic mutant, pinotage, providing an important link in our understanding of the relationship between mitochondrial homeostasis and haem synthesis and identifying a gene that may have a role in human iron, haem and mitochondrial diseases. Defects in haem biosynthesis in erythrocytes cause anaemia. Many of the enzymes and substrates involved in this important process are known, but it is still unclear how iron transport is regulated in the mitochondria and coordinated with haem homeostasis. Here, Barry Paw and colleagues report the cloning of mitochondrial ATPase inhibitor factor 1 (atpif1) from a zebrafish genetic screen. Atpif1 regulates ferrochelatase, the terminal enzyme in haem biosynthesis, through alteration of mitochondrial pH and redox potential in the presence of a [2Fe–2S] cluster as the iron supply. The authors show that the human orthologue of Atpif1 is vital for normal red-blood-cell differentiation, suggesting that its deficiency may contribute to human diseases such as congenital sideroblastic anaemias and other mitochondriopathies. Defects in the availability of haem substrates or the catalytic activity of the terminal enzyme in haem biosynthesis, ferrochelatase (Fech), impair haem synthesis and thus cause human congenital anaemias1,2. The interdependent functions of regulators of mitochondrial homeostasis and enzymes responsible for haem synthesis are largely unknown. To investigate this we used zebrafish genetic screens and cloned mitochondrial ATPase inhibitory factor 1 (atpif1) from a zebrafish mutant with profound anaemia, pinotage (pnt tq209 ). Here we describe a direct mechanism establishing that Atpif1 regulates the catalytic efficiency of vertebrate Fech to synthesize haem. The loss of Atpif1 impairs haemoglobin synthesis in zebrafish, mouse and human haematopoietic models as a consequence of diminished Fech activity and elevated mitochondrial pH. To understand the relationship between mitochondrial pH, redox potential, [2Fe–2S] clusters and Fech activity, we used genetic complementation studies of Fech constructs with or without [2Fe–2S] clusters in pnt, as well as pharmacological agents modulating mitochondrial pH and redox potential. The presence of [2Fe–2S] cluster renders vertebrate Fech vulnerable to perturbations in Atpif1-regulated mitochondrial pH and redox potential. Therefore, Atpif1 deficiency reduces the efficiency of vertebrate Fech to synthesize haem, resulting in anaemia. The identification of mitochondrial Atpif1 as a regulator of haem synthesis advances our understanding of the mechanisms regulating mitochondrial haem homeostasis and red blood cell development. An ATPIF1 deficiency may contribute to important human diseases, such as congenital sideroblastic anaemias and mitochondriopathies.

19 August 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
Amy MedlockAmy Medlock
Amy Medlock
MSMesafint T. Shiferaw
Mesafint T. Shiferaw
JMJason R. Marcero
Jason R. Marcero
AVAjay A. Vashisht
Ajay A. Vashisht
JWJames A. Wohlschlegel
James A. Wohlschlegel
HDHarry A. Dailey
Harry A. Dailey
Heme is an essential cofactor for most organisms and all metazoans. While the individual enzymes involved in synthesis and utilization of heme are fairly well known, less is known about the intracellular trafficking of porphyrins and heme, or regulation of heme biosynthesis via protein complexes. To better understand this process we have undertaken a study of macromolecular assemblies associated with heme synthesis. Herein we have utilized mass spectrometry with coimmunoprecipitation of tagged enzymes of the heme biosynthetic pathway in a developing erythroid cell culture model to identify putative protein partners. The validity of these data obtained in the tagged protein system is confirmed by normal porphyrin/heme production by the engineered cells. Data obtained are consistent with the presence of a mitochondrial heme metabolism complex which minimally consists of ferrochelatase, protoporphyrinogen oxidase and aminolevulinic acid synthase-2. Additional proteins involved in iron and intermediary metabolism as well as mitochondrial transporters were identified as potential partners in this complex. The data are consistent with the known location of protein components and support a model of transient protein-protein interactions within a dynamic protein complex.

6 September 2016 in Biochemistry
Verified
Journal Article
Closed access
RPRobert B. Piel
Robert B. Piel
MSMesafint T. Shiferaw
Mesafint T. Shiferaw
AVAjay A. Vashisht
Ajay A. Vashisht
JMJason R. Marcero
Jason R. Marcero
JPJeremy L. Praissman
Jeremy L. Praissman
Amy MedlockAmy Medlock
Amy Medlock